Related Experiment Video

Updated: Oct 9, 2025

Generation of a RIP1 Knockout U937 Cell Line Using the CRISPR-Cas9 System
08:15

Generation of a RIP1 Knockout U937 Cell Line Using the CRISPR-Cas9 System

Published on: April 11, 2025

490

RKIP Pleiotropic Activities in Cancer and Inflammatory Diseases: Role in Immunity

Roni Touboul1, Stavroula Baritaki2, Apostolos Zaravinos3,4

  • 1Department of Microbiology, Immunology & Molecular Genetics, David Geffen School of Medicine at UCLA, University of California at Los Angeles, Los Angeles, CA 90095, USA.

Cancers
|December 24, 2021
PubMed

Insights

Raf kinase inhibitory protein (RKIP) regulates cancer and immune responses. Its deregulation impacts oncogenesis and immune diseases, suggesting RKIP as a potential therapeutic target for cancer and inflammation.

Area of Science:

  • Molecular Biology
  • Immunology
  • Oncology

Background:

  • Raf kinase inhibitory protein (RKIP) is a key regulator of cellular processes.
  • RKIP deregulation is implicated in oncogenesis and immune-mediated diseases.
  • Understanding RKIP's multifaceted roles is crucial for disease intervention.

Purpose of the Study:

  • To review the general properties of RKIP.
  • To elucidate RKIP's involvement in critical cell signaling pathways.
  • To explore RKIP's role in cancer and immune system regulation.

Main Methods:

  • Literature review of RKIP's molecular structure and functions.
  • Analysis of RKIP's involvement in signaling pathways (Raf/MEK/ERK, NF-kB, STAT-3, etc.).
  • Examination of RKIP's role in oncogenesis, immune cell function, and inflammatory diseases.

Main Results:

  • RKIP modulates multiple signaling cascades, including those controlling cell growth and inflammation.
  • RKIP expression is altered in various cancers and inflammatory conditions.
  • RKIP influences T cell functions, cytokine secretion, apoptosis, and immune checkpoints.

Conclusions:

  • RKIP exhibits pleiotropic activities relevant to cancer and immune diseases.
  • RKIP's regulatory roles in diverse cellular processes highlight its significance.
  • RKIP represents a promising therapeutic target for treating cancers and inflammatory disorders.
Keywords:
RKIPT cellsautoimmunitycancerimmunosuppressionimmunotherapy

More Related Videos

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice08:43

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice

Published on: January 31, 2020

7.0K
Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle10:05

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle

Published on: March 5, 2019

6.6K

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.5K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.5K
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
10.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K